Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 3, 1997, Pages 213-220

  Ohashi, Yoshihiro ^a   Nakai, Yoshiaki ^a   Tanaka, Ayaki ^a   Kakinoki, Yasushi ^a   Ohno, Yoshiharu ^a   Masamoto, Tateo ^a   Sakamoto, Hirokazu ^a   Kato, Akifumi ^a   Washio, Yushi ^a   Hayashi, Motoyo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; TERFENADINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INFLAMMATION; MAJOR CLINICAL STUDY; PATHOGENESIS; POLLEN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION;

EID: 0030666503     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63004-9     Document Type: Article

References (20)

1. Rubin LA, Kurman CG, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-7.
2. Ohashi Y, Nakai Y, Sakamato H, et al. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy. Ann Allergy Asthma Immunol 1996;77:203-8.
3. Ohashi Y, Tanaka A, Kakinoki Y, et al. Serum level of soluble interleukin-2 receptor in patients with seasonal allergic rhinitis. Scand J Immunol 1997;45:315-21.
4. Nash MC, Wada AM, Shah V, et al. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol 1996;103:167-70.
5. Sessler CN, Windsor AC, Schwartz M, et al. Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 1995;151:1420-7.
6. Furukawa S, Imai K, Matsubara T, et al. Increased levels of circulating intercellular adhesion molecules-1 in Kawasaki disease. Arthritis Rheum 1992; 35:672-7.
7. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991;85:3-8.
8. Kojima T, Ohno A, Aoki T, et al. Circulating ICAM-1 levels in children with atopic dermatitis. Ann Allergy 1994;73:351-5.
9. Hashimoto S, Imai K, Kobayashi T, et al. Elevated levels of soluble ICAM-1 in sera from patients with bronchial asthma. Allergy 1993;48:370-2.
10. Chihara J, Yamamoto T, Kurachi D, Nakajima S. Soluble ICAM-1 in sputum of patients with bronchial asthma. Lancet 1994;343:1108.
11. Montefort S, Lai CKW, Kapahi P, et al. Circulating adhesion molecules in asthma. Am J Respir Crit Care Med 1994;149:1149-52.
12. Kato M, Hattori T, Kitamura M, et al. Soluble ICAM-1 as a regulator of nasal allergic reaction under natural allergen provocation. Clin Exp Allergy 1995;25:744-8.
13. Takahashi N, Liu MC, Proud D, et al. Soluble intercellular adhesion molecule 1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. Am J Respir Crit Care Med 1994;150:704-9.
14. Okuda M, Ishikawa T, Saito Y, et al. A clinical evaluation of N'-5 with perennial-type allergic rhinitis. A test by multi-clinic, intergroup, double-blind comparative method. Ann Allergy 1984;53:178-85.
15. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990;24:606-9.
16. Boccagni P, Favari F, Zanoni G. Comparison of four in vitro assays for specific IgE detection. Int J Clin Lab Res 1994;24:102-5.
17. Chilosi M, Semenzato G, Cetto G, et al. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987;70:1530-5.
18. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
19. Brunet C, Bedard PM, Lavoie A, et al. Allergic rhinitis to ragweed pollen. 1. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol 1992;89:76-86.
20. Ohashi Y, Tanaka A, Kakinoki Y, et al. Effect of immunotherapy on seaonal changes in serum specific IgE and IgG4 in patients with pollen allergic rhinitis. Laryngoscope (in press).